Sang-A Pharm seeking to produce generic drugs

Published: 2003-06-18 06:57:00

Updated: 2003-06-18 06:57:00

Sang-A Pharm said that as part of diversifying its business sector and sales boost, it has recently set up FineChem., a drug synthesis corporation, with a pain-in capital of 500 million won in a bid to meet the increasing demand of generic drugs which has been influenced by the government drug-re...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK